Page 9 - Crispr News Today

Utilizing CRISPR genome editing to modify genes for developing cellular models for drug discovery

InnovationRx is your weekly digest of healthcare news. Sign up!

If looking back at 2023 brings forth visions of dumpster fires in your head, take heart: There were some pretty amazing accomplishments over the past 12 months, notably on the...

A virus engineered using CRISPR technology spread its DNA to other viruses in mice, causing them to become harmless

2023 saw big shifts in the macroeconomics of the biotech sector, but also major technological milestones for longer, healthier lives.

Modifying a patient’s DNA is no longer just for science fiction novels. The CRISPR gene editing technique developed by Jennifer Doudna and Emmanuelle Charpentier only took 10 years to reach the market as Casgevy (exagamglogene autotemcel/exa-cel, Vertex Pharmaceuticals Inc.), treating congenital pathologies such as β-thalassemia and severe sickle cell disease (SCD). But science does not stop.

Excision BioTherapeutics has so far released positive safety data from the first 3 participants living with HIV-1, with no evidence of vector shedding in sexual organ tissue.

New forms of the gene-editing tool could enable treatments for common diseases.

A life-saving gene therapy to treat sickle cell disease has been FDA approved. The first patient to receive the treatment came to Nashville to be part of a clinical trial years ago.

InnovationRx is your weekly digest of healthcare news. Sign up!